Back to results
US 2016/0106882 A1Published application
Degradable haemostat composition
AssigneeMedtrade Products Limited
InventorsCraig Hardy, Andrew Hoggarth, June Gladman
Life of this patent
Estimating the term…
Abstract
The present invention relates to a haemostat composition that is able to safely gradually and fully degrade in a human or animal body within about 30 days and so can be utilised by physicians to stem a flow of blood and promote healing both after as well as during surgical procedures.
Claims32
A haemostat composition comprising a chitosan, chitosan salt or chitosan derivative, wherein the haemostat composition is in a non-fibrous form, and is able to fully degrade in a human or animal body within about 30 days.
(canceled)
Dependencies are inferred from the claim text.